ABT‐199 (Venetoclax), a BH3‐mimetic Bcl‐2 inhibitor, does not cause Ca 2+ ‐signalling dysregulation or toxicity in pancreatic acinar cells-Reference-Cited by-同舟云学术

ABT‐199 (Venetoclax), a BH3‐mimetic Bcl‐2 inhibitor, does not cause Ca 2+ ‐signalling dysregulation or toxicity in pancreatic acinar cells

Published:2018-11-08 Issue:22 Volume:176 Page:4402-4415
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Jakubowska Monika A¹²^ORCID,Kerkhofs Martijn³^ORCID,Martines Claudio⁴^ORCID,Efremov Dimitar G⁴^ORCID,Gerasimenko Julia V¹^ORCID,Gerasimenko Oleg V¹^ORCID,Petersen Ole H¹^ORCID,Bultynck Geert³^ORCID,Vervliet Tim³^ORCID,Ferdek Pawel E¹⁵^ORCID

Affiliation:

1. Medical Research Council Group, School of BiosciencesCardiff University Cardiff UK

2. International Associated Laboratory (LIA), Malopolska Centre of BiotechnologyJagiellonian University Krakow Poland

3. Laboratory of Molecular and Cellular Signaling, Department of Cellular and Molecular MedicineKU Leuven Leuven Belgium

4. Molecular Hematology UnitInternational Centre for Genetic Engineering and Biotechnology Trieste Italy

5. Department of Cell Biology, Faculty of Biochemistry, Biophysics and BiotechnologyJagiellonian University Krakow Poland

Funder

Associazione Italiana per la Ricerca sul Cancro

Fundacja na rzecz Nauki Polskiej

CHILDREN with CANCER UK

Fonds Wetenschappelijk Onderzoek

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14505

Reference66 articles.

1. The Bcl-2 apoptotic switch in cancer development and therapy

2. HA14-1, but not the BH3 mimetic ABT-737, causes Ca2+ dysregulation in platelets and human cell lines

3. A dual role for the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus endoplasmic reticulum

4. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview

5. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria of T Lymphocytes Promote Anti-Pulmonary Tumor Immune Response;World Journal of Oncology;2024-06

2. Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers;Cancers;2023-10-12

3. Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium;2023-10-03

4. Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight;International Journal of Molecular Sciences;2023-03-14

5. Driver Mutations of Pancreatic Cancer Affect Ca2+ Signaling and ATP Production;Function;2023